Breast cancer and hormonal replacement therapy

Annals of the New York Academy of Sciences

Volumn 997, Issue , 2003, Pages 341-350

  Vassilopoulou Sellin, Rena ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Breast cancer; Hormonal replacement therapy; Menopause

Indexed keywords

ESTROGEN; GESTAGEN; HORMONE;

BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER RECURRENCE; CANCER RISK; CANCER THERAPY; CLINICAL PRACTICE; CONFERENCE PAPER; ESTROGEN THERAPY; HUMAN; LONG TERM CARE; MEDICAL DECISION MAKING; MENOPAUSAL SYNDROME; POSTMENOPAUSE; RISK ASSESSMENT; TREATMENT CONTRAINDICATION; AGE DISTRIBUTION; AGED; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; INCIDENCE; MENOPAUSE; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY; REVIEW; UNITED STATES;

AGE DISTRIBUTION; AGED; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HORMONE REPLACEMENT THERAPY; HUMANS; INCIDENCE; MENOPAUSE; MIDDLE AGED; RISK ASSESSMENT; UNITED STATES;

EID: 0642303149     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1290.037     Document Type: Conference Paper

References (70)

1. ARMSTRONG, B.K. 1998. Estrogen therapy after the menopause - boon or bane? Med. J. Aust. 148: 213-214.
2. STEINBERG, K.K., S.B. TRACKER, S.J. SMITH, et al. 1990. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA 265: 1985-1990.
3. SILERO-ARENAS, M., M. DELGADO-RODRIGUEZ, R. RODIGUES-CANTERAS, et al. 1992. Menopausal hormone replacement therapy and breast cancer: a meta-analysis. Obstet. Gynecol. 79: 286-294.
4. COLDITZ, G.A., K.M. EGAN, M.J. STAMPFER, et al. 1993. Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies. Am. J. Obstet. Gynecol. 68: 1473-1480.
5. COLLABORATIVE GROUP ON HORMONAL FACTORS IN BREAST CANCER. 1997. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 350: 1047-1059.
6. KAUFMAN, D.W., J.R. PALMER, J. DE MOUZON, et al. 1991. Estrogen replacement therapy and the risk of breast cancer: result from the case-control surveillance study. Am. J. Epidemiol. 34: 1375-1385.
7. HEINRICH, J.B. 1992. The postmenopausal estrogen/breast cancer controversy. JAMA 268: 1900-1902.
8. HOOVER, R., A. GLASS, W.D. FINKLE, et al. 1981. Conjugated estrogens and breast cancer risk in women. JNCI 67: 815-820.
9. BERGKVIST, L., H.O. ADAMI, I. PERSSON, et al. 1989. The risk of breast cancer after estrogen and estrogen-progesterone replacement. N. Engl. J. Med. 321: 293-297.
10. BRINTON, L.A., R. HOOVER & J.F. FRAUMENI. 1986. Menopausal estrogens and breast cancer risk: an expanded case-control study. Br. J. Cancer 54: 825-832.
11. WINGO, P.A., P.M. LAYDE, N.C. LEE, et al. 1987. The risk of breast cancer in postmenopausal women who have used estrogen replacement therapy. JAMA 257: 209-215.
12. BURING, J.E., C.H. HENNEKENS, R.J. LIPNICK, et al. 1987. A prospective cohort study of postmenopausal hormone use and risk of breast cancer in US women. Am. J. Epidemiol. 125: 939-947.
13. EWERTZ, M. 1988. Influence of non-contraceptive exogenous and endogenous sex hormones on breast cancer risk in Denmark. Int. J. Cancer 42: 832-838.
14. COLDITZ, G.A., M.J. STAMPFER, W.C. WILLETT, et al. 1990. Prospective study of estrogen replacement therapy and risk of breast cancer in postmenopausal women. JAMA 264: 2648-2653.
15. BARRETT-CONNOR, E. 1992. Risks and benefits of replacement estrogen. Annu. Rev. Med. 43: 239-251.
16. CLINICAL GUIDELINE. 1992. Guidelines for counseling postmenopausal women about preventive hormone therapy. Ann. Intern. Med. 117: 1038-1041.
17. DUPONT, W.D. & D.L. PAGE. 1991. Menopausal estrogen replacement therapy and breast cancer. Arch. Int. Med. 151: 67-72.
18. GRADY, D., S.M. RUBIN, D.B. PETITTI, et al. 1992. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann. Intern. Med. 117: 1016-1037.
19. LANDO, J.F., K.E. HECK & K.M. BRETT. 1999. Hormone replacement therapy and breast cancer risk in a nationally representative cohort. Am. J. Prev. Med. 17: 176-180.
20. SANTEN, R.J., J. PINKERTON, C. MCCARTNEY, et al. 2000. Clinical Review 121: risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy. J. Clin. Endocrinol. Metab. 86: 16-23.
21. SCHAIRER, C., J. LUBIN, R. TROISI, et al. 2000. Menopausal estrogen and estrogenprogestin replacement therapy and breast cancer risk. JAMA 283: 485-535.
22. ROSS, R. K., A. PAGANINI-HILL, P.C. WAN, et al. 2000. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J. Natl. Cancer Inst. 92: 328-332.
23. WRITING GROUP FOR THE WOMEN'S HEALTH INITIATIVE INVESTIGATORS. 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 288: 321-333.
24. DUPONT, W.D., D.L. PAGE, L.W ROGERS, et al. 1989. Influence of exogenous estrogens, proliferative breast disease and other variables on breast cancer risk. Cancer 63:
25. GREENDALE, G.A. & H.L. JUDD. The menopause: health implications and clinical management. J. Am. Geriatr. Soc. 41: 426-436.
26. KRONNENBERG, F. 1990. Hot flashes: epidemiology and physiology. Ann. N.Y. Acad. Sci. 592: 52-86.
27. UTIAN, W.H. & I. SCHIFF. 1994. NAMS-Gallup survey on women's knowledge, information sources, and attitudes to menopause and hormone replacement therapy. Menopause 1: 39-48.
28. RIGGS, B.L. & L.J. MELTON. 1992. The prevention and treatment of osteoporosis. N. Engl. J. Med. 327: 620-627.
29. WENGER, N.K., L. SPEROFF & B. PACKARD. 1993. Cardiovascular health in women. N. Engl. J. Med. 329: 247-256.
30. LINDSAY, R., D.M. HART, C. FORREST, et al. 1989. Prevention of spinal osteoporosis in oophorectomized women. Lancet 2: 1151-1154.
31. ETTINGER, B. 1990. Hormone replacement therapy and coronary heart disease. Obstet. Gynecol. Clin. North Am. 17: 741-757.
32. GRODSTEIN, F., M.J. STAMPFER, G.A. COLDITZ, et al. 1997. Postmenopausal hormone therapy and mortality. N. Engl. J. Med. 336: 1769-1775.
33. HUMPHREY, L.L., B.K.S. CHAN, H.C. SOX. 2002. Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease. Ann. Int. Med. 137: 273-284.
34. DEPARTMENT OF RESEARCH AND EVALUATION, KAISER PERMANENTE SOUTHERN CALIFORNIA, PASADENA. 1998. Hormone replacement therapy and heart disease prevention: experimentation trumps observation. JAMA 280: 650-652.
35. HULLEY, S., D. GRADY, T. BUSH, et al. 1998. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280: 605-613.
36. GRODSTEIN, F., J.E. MANSON & M.J. STAMPFER. 2001. Postmenopausal hormone use and secondary prevention of coronary events in the nurses' health study. Ann. Intern. Med. 135: 1-8.
37. HERRINGTON, D.M., D.M. REBOUSSIN, K.B. BROSHIHAN, et al. 2000. Effects of estrogen replacement on the progression of coronary-artery atheroclerosis. N. Engl. J. Med. 343: 522-529.
38. GRADY, D., N.K. WENGER, D. HERRINGTON, et al. 2000. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. Ann. Intern. Med. 132: 689-696.
39. HARDING, C., W.F. KNOX, E.B. FARAGHER, et al. 1996. Hormone replacement therapy and tumor grade in breast cancer: prospective study in screening unit. BMJ. 312: 1646-1647.
40. BONNIER, P., F. BESSENAY, A.J. SASCO, et al. 1998. Impact of menopausal hormone replacement therapy on clinical and laboratory characteristics of breast cancer. Int. J. Cancer 79: 278-282.
41. GAPSTUR, S.M., M. MORROW & T.A. SELLERS. 1999. Hormone replacement therapy and risk of breast cancer with a favorable histology. JAMA 28: 2091-2141.
42. SQUITIERI, R., P.I. TARTTE & S. AHMED. 1994. Carcinoma of the breast in postmenopausal hormone user and nonuser control groups. J. Am. Coll. Surg. 178: 167-170.
43. MAGNUSSOM, C., L. HOMBERG, T. NORDEN, et al. 1996. Prognosis characteristics in breast cancers after hormone replacement therapy. Breast Cancer Res. Treat 38: 325-334.
44. HOLLI, K., J. ISOLA & J. CUZIC. 1998. Low biologic aggressiveness in breast cancer in women using hormone replacement therapy. J. Clin. Oncol. 16: 3115-3120.
45. BERKVIST, L., H.O. ADAMI, I. PERSSON, et al. 1989. Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy. Am. J. Epidemiol. 130: 221-228.
46. STRICKLAND, D.M., D. GAMBRELL & A. CLIFFORD. 1992. The relationship between breast cancer survival and prior postmenopausal estrogen. Obstet. Gynecol. 80: 400-404.
47. YUEN, J., I. PERSSON, L. BERGKVIST, et al. 1993. Hormone replacement therapy and breast cancer mortality in Swedish women: results after adjustment for healthy drug-users' effect. Cancer Causes Control 4: 369-374.
48. FOWBLE, B., A. HANLON, G. FREEDMAN, et al. 1999. Postmenopausal hormone replacement therapy: effect on diagnosis and outcome in early-stage invasive breast cancer treated with conservative surgery and radiation. J. Clin. Oncol. 17: 1680-1688.
49. HUNT, K., M. VESSEY & K. MCPHERSON. 1990. Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis. Br. J. Obstet. Gynaecol. 97: 1080-1086.
50. JERNSTROM, J., J. FRENANDER, M. FERNO, et al. 1999. Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never-use among 984 breast cancer patients. Br. J. Cancer 80: 1453-1458.
51. WILLIS, D.B., E.E. CALLE, H.L. MIRACLE-MCMAHILL, et al. 1996. Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United States. Cancer Causes Control 7: 449-457.
52. SHAIRER, C., M. GAIL, C. BYRNE, et al. 1999. Estrogen replacement therapy and breast cancer survival in a large screening study. J. Natl. Cancer Inst. 91: 264-269.
53. SELLERS, T.A., P.J. MINK, J.R. CERHAN, et al. 1997. The role of hormone replacement therapy in the risk for breast cancer and total mortality in women with a family history of breast cancer. Ann. Intern. Med. 127: 973-980.
54. HABEL, L.A., J.R. DALING, P.A. NEWCOMB, et al. 1998. Risk of recurrence after ductal carcinoma in situ of the breast. Cancer Epidemiol. Biomark. Prev. 7: 689-696.
55. STOLL, B.A. & S.L. PARBHOO. 1998. Treatment of menopausal symptoms in breast cancer patients. Lancet 1: 1278-1279.
56. EDEN, J.A. 1992. Estrogen and the breast. The management of the menopausal woman with breast cancer. Med. J. Aust. 157: 247-250.
57. LOBO, R.A. 1993. Hormone replacement therapy. Estrogen replacement after treatment for breast cancer? Lancet 341: 1313-1314.
58. MARCHANT, D.J. 1993. Estrogen-replacement therapy after breast cancer. Risks versus benefits. Cancer 71: 2169-2176.
59. VASSILOPOULOU-SELLIN, R. 1993. Estrogen replacement therapy in women at increased risk for breast cancer. Breast Cancer Res. Treat. 28: 167-177.
60. VASSILOPOULOU-SELLIN, R., L. ASMAR, G.N. HORTOBAGYI, et al. 1999. Estrogen replacement therapy after localized breast cancer: clinical outcome of 319 women followed prospectively. J. Clin. Oncol. 17: 1482-1487.
61. POWLES, T.J., T. HICKISH, S. CASEY, et al. 1993. Hormone replacement after breast cancer. Lancet 342: 60-61.
62. EDEN, J.A., T. BUSH & S. NAND. 1995. A case-control study of combined continuous estrogen-progestin replacement therapy among women with a personal history of breast cancer. Menopause 2: 67-72.
63. DISAIA, P.J., E.A. GROSEN, T. KUROSAKI , et al. 1996. Hormone replacement therapy in breast cancer survivors: a cohort study. Am. J. Obstet. Gynecol. 174: 1494-1498.
64. VASSILOPOULOU-SELLIN, R., R. THERIAULT & M.J. KLEIN. 1997. Estrogen replacement therapy in women with prior diagnosis and treatment of breast cancer. Gynecol. Oncol. 65: 89-93.
65. PETERS, G.N. & S.E. JONES. 1996. Estrogen replacement therapy in breast cancer patients. A time for change? Proc. Am. Soc. Clin. Oncol. 15: 121A.
66. DECKER, D., T. Cox, I. BURDAKIN, et al. 1996. Hormone replacement therapy (HRT) in breast cancer survivors. Proc. Am. Soc. Clin. Oncol. 15: 136A.
67. GORINS, A., A. CREMIEU, M. ESPIE, et al. 1997. Hormone replacement therapy (HRT) in women with previously treated primary breast cancer. Update III. Proc. Am. Soc. Clin. Oncol. 16: 131.
68. BLUMING, A.Z., J.R. WAISMAN, G.M. DOSIK, et al. 1997. Hormone replacement therapy (HDT) in women with previously treated primary breast cancer. Update II. Proc. Am. Soc. Clin. Oncol. 16: 131A.
69. MARSDEN, J. & N.P.M. SACKS. 1997. Hormone replacement therapy and breast cancer. Endocr. Related Cancer 4: 269-279.
70. VASSILOPOULOU-SELLIN, R., D.S. COHEN, G.N. HORTOBAGYI, et al. 2002. Estrogen replacement therapy (ERT) for menopausal women with a history of breast cancer: results of a 5-year, prospective study. Cancer 95: 1817-1826.